Lifitegrast is an FDA approved drug indicated for the treatment of signs and symptoms of dry eye, a syndrome called keratoconjunctivitis sicca. Lifitegrast reduces inflammation by inhibiting inflammatory cell binding. Read More
Three government-run hospitals in Gujarat have adopted the latest LiFi (Light Fidelity) technology to treat COVID-19 patients and the results have been very impressive. ...